Top Analyst Upgrades and Downgrades: ADP, Bluebird Bio, DaVita, First Solar, Square, SunPower, US Steel and More

Print Email

Stocks recently hit all-time highs, and they were indicated to open marginally higher on Monday. The trend that has continued to prevail is investors buying all the big market sell-offs. Investors are also looking for new investing and trading ideas to generate gains and income ahead.

24/7 Wall St. reviews dozens of analyst research reports each day of the week. Our goal is to find new investing and trading ideas for investors and traders alike. Some daily analyst reports and research reports cover stocks to buy. Others cover stocks to sell or to avoid.

Additional color and commentary has been added on most of these daily analyst calls. The consensus analyst price targets mentioned and other valuation metrics are from the Thomson Reuters sell-side research service.

These were the top analyst upgrades, downgrades and other research calls from Monday, December 11, 2017.

Air Products and Chemicals Inc. (NYSE: APD) was raised to Buy from Hold and the price target was raised to $185 from $166 (versus a $160.92 prior close) at Jefferies. The shares were up 1.4% at $163.17 on Monday morning.

Attunity Ltd. (NASDAQ: ATTU) was started as Buy and assigned a $13 price target (versus a $6.82 close) at Needham. This may be a call for the stock to double, but Attunity, a seller of big data management software solutions, had a market cap of only about $117 million and a consensus analyst target price of $11.83 on last look.

Automatic Data Processing Inc. (NASDAQ: ADP) was raised to Buy from Neutral with a $135 price target (versus a $116.02 close) at Goldman Sachs. ADP has a 52-week trading range of $94.11 to $121.77 and a consensus target price of $112.95.

Bluebird Bio Inc. (NASDAQ: BLUE) was raised to Buy from Hold and the price target was raised to $211 from $130 (versus a $171.15 close) at Jefferies. Bluebird Bio was said to have compelling clinical data from its bb2121 program in multiple myeloma, and the firm thinks currently the durability is Darzalex-like and could improve further. Cantor Fitzgerald maintained its Underweight rating but raised its target price to $113 from $58.

Brookfield Property Partners L.P. (NYSE: BPY) was downgraded to In-Line from Outperform at Evercore ISI.

DaVita Inc. (NYSE: DVA) was raised to Buy from Neutral with an $82 price target (versus a $67.71 close) at Citigroup. The 52-week range is $52.51 to $70.16, and the consensus price target is $69.45.

Discover Financial Services (NYSE: DFS) was raised to Overweight from Equal Weight at Barclays.

Essex Property Trust Inc. (NYSE: ESS) was raised to Outperform from In-Line at Evercore ISI.

First Solar Inc. (NASDAQ: FSLR) was raised to Outperform from Neutral with an $82 price target (versus z $70.02 close) at Robert W. Baird. It has a 52-week range of $25.56 to $70.27 and a consensus target price of $64.90.

Hologic Inc. (NASDAQ: HOLX) was raised to Outperform from Market Perform at Cowen. Shares were indicated up 1.25% at $43.25 on Monday.

Illinois Tool Works Inc. (NYSE: ITW) was started with a Buy rating and assigned a $190 price objective (versus a $166.49 close) at Merrill Lynch.

Lexington Realty Trust (NYSE: LXP) was downgraded to In-Line from Outperform at Evercore ISI.

Macerich Co. (NYSE: MAC) was downgraded to Underperform from In-Line at Evercore ISI.

Magellan Midstream Partners L.P. (NYSE: MMP) was started as Outperform with an $80 price target (versus a $67.10 close) at BMO Capital Markets.